Colorectal Cancer Early Detection Act
- Sponsor
- Sen. Ossoff, Jon [D-GA]
- Committees
- Health, Education, Labor, and Pensions Committee (primary)
- Last action
- Aug 6, 2026
Bottom line
The bill establishes a federal grant program to help states address the rising incidence of colorectal cancer in younger populations through targeted awareness, education, and early detection initiatives.
What it actually does
This bill authorizes the Secretary of Health and Human Services, through the Director of the Centers for Disease Control and Prevention (CDC), to establish a competitive grant program for States. The grants are intended to increase awareness, education, and early detection of colorectal cancer in young individuals, defined as those under the age of 45, with a particular focus on high-risk populations and underserved communities.
Proponents argue
Proponents argue that this bill is a critical response to the alarming increase in colorectal cancer rates among young individuals, which is projected to become the leading cause of cancer-related deaths for those under 50 by 2030. They contend that early detection is key to improving outcomes and that a federal grant program will provide states with the necessary resources and guidance to implement effective, targeted public health strategies.
Opponents contend
Potential critics might raise concerns about the efficiency of competitive grant programs, suggesting they could lead to uneven distribution of resources or administrative burdens for states. Some may also argue that while the issue is important, federal intervention might not be the most effective or fiscally responsible approach compared to state-led initiatives or broader healthcare reforms.
The bill is concise and clearly written, allowing for a quick and comprehensive understanding of its provisions.
Section 3(b)
Establishment of CDC State Grant Program
This provision authorizes the Secretary of Health and Human Services, acting through the Director of the Centers for Disease Control and Prevention (CDC), to make grants to States. These grants are to be awarded on a competitive basis, with the explicit purpose of increasing awareness, education, and early detection efforts for colorectal cancer specifically among young individuals, defined as those who have not yet reached the age of 45.
Supporters argue
Supporters argue that this grant program is essential to provide states with the resources needed to combat the rising incidence of colorectal cancer in younger populations, ensuring that critical early detection and awareness efforts can be scaled effectively.
Critics contend
Critics might contend that a competitive grant structure could disadvantage states with fewer resources or less experience in grant writing, potentially leading to an uneven distribution of crucial public health funding.
Tradeoffs
The competitive nature of the grants aims to fund the most effective proposals but may leave some states without resources to address a widespread public health issue.
Section 3(c)
Targeted Outreach and Education Requirements for Grant Applications
To receive a grant, States must submit a detailed plan outlining how they will conduct outreach and provide education. This plan must specifically emphasize young individuals with increased risk factors (e.g., family history, inflammatory bowel disease, inherited syndromes, specific symptoms like rectal bleeding, type 2 diabetes) and individuals in underserved and rural areas, including American Indian, Alaska Native, and African American communities. The goal is to identify high-risk individuals for early detection before age 45 and educate others for detection at age 45.
Section 3(d)
Permitted Uses of Grant Funds
This section outlines how States can use the grant funds. Primarily, funds must support early detection and diagnostic testing for young individuals identified as high-risk. Additionally, funds may be used for a wide range of activities including providing referrals for medical treatment (including genetic testing and counseling), developing public awareness campaigns, educating health professionals on screening and diagnostics, monitoring the quality of screening procedures, conducting surveillance for risk factors, developing strategies to capture family history, establishing patient navigation support, designing clinician decision support tools, and monitoring and evaluating all funded activities.
The bill authorizes 'such sums as may be necessary' to be appropriated to carry out the grant program.
Section 3(g)
Why it matters:This phrasing is a common legislative practice that authorizes a program without committing to a specific funding level. It defers the actual funding decision to future appropriations bills, allowing flexibility for Congress to adjust spending based on economic conditions and priorities. It is not necessarily evasive but means the program's actual scale is not guaranteed.
Case for: Supporters argue that this approach provides flexibility, allowing appropriations committees to determine the most appropriate funding levels in future budget cycles based on evolving needs and fiscal realities, without requiring a new authorization bill.
Case against: Critics might contend that authorizing 'such sums as may be necessary' provides no guaranteed funding, making the program's implementation and long-term effectiveness uncertain and dependent on the political will of future Congresses to appropriate sufficient funds.
Estimated impact: The actual financial impact and the scale of the grant program are entirely contingent upon future appropriations decisions by Congress.